A Clinical Trial With Dimethyl Sulfoxide in Scleroderma

Abstract
In view of enthusiastic reports concerning the use of dimethyl sulfoxide in scleroderma, a clinical trial with this agent was carried out. Twenty-four patients with systemic scleroderma were treated with local applications of dimethylsulfoxide. Under the conditions of this study, no improvement of any of the parameters studied was noted.

This publication has 0 references indexed in Scilit: